STERIS plc (STE)

Cash ratio

Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Cash and cash equivalents US$ in thousands 171,701 155,178 172,195 198,328 207,020 195,585 213,757 208,614 208,357 259,371 258,259 316,327 348,320 359,089 383,494 534,774 220,531 252,502 312,028 255,627
Short-term investments US$ in thousands
Total current liabilities US$ in thousands 1,022,170 891,120 805,483 834,360 931,127 913,694 873,115 886,911 861,844 796,457 872,815 908,323 922,222 904,307 785,701 1,145,020 577,920 505,867 435,418 479,549
Cash ratio 0.17 0.17 0.21 0.24 0.22 0.21 0.24 0.24 0.24 0.33 0.30 0.35 0.38 0.40 0.49 0.47 0.38 0.50 0.72 0.53

March 31, 2025 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($171,701K + $—K) ÷ $1,022,170K
= 0.17

The cash ratio of STERIS plc has shown a general declining trend over the analyzed period, dropping from 0.53 as of June 30, 2020, to 0.17 as of March 31, 2025. This indicates a decreasing ability of the company to cover its short-term liabilities with its available cash and cash equivalents. The ratio fluctuated within the range of 0.17 to 0.72 during this period, with notable declines in the second half of 2021 and into 2022. This may suggest potential cash flow challenges or a shift in the company's liquidity management strategies. It is important for STERIS plc to monitor its cash position and liquidity closely to ensure it can meet its financial obligations as they come due.